74 related articles for article (PubMed ID: 8349790)
21. Serologic testing in inflammatory bowel disease: its value in indeterminate colitis.
Papadakis KA; Targan SR
Curr Gastroenterol Rep; 1999 Dec; 1(6):482-5. PubMed ID: 10980990
[TBL] [Abstract][Full Text] [Related]
22. HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations.
Trachtenberg EA; Yang H; Hayes E; Vinson M; Lin C; Targan SR; Tyan D; Erlich H; Rotter JI
Hum Immunol; 2000 Mar; 61(3):326-33. PubMed ID: 10689124
[TBL] [Abstract][Full Text] [Related]
23. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope.
Cohavy O; Bruckner D; Gordon LK; Misra R; Wei B; Eggena ME; Targan SR; Braun J
Infect Immun; 2000 Mar; 68(3):1542-8. PubMed ID: 10678972
[TBL] [Abstract][Full Text] [Related]
24. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.
Sutton CL; Yang H; Li Z; Rotter JI; Targan SR; Braun J
Gut; 2000 Jan; 46(1):58-63. PubMed ID: 10601056
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease.
Cohavy O; Harth G; Horwitz M; Eggena M; Landers C; Sutton C; Targan SR; Braun J
Infect Immun; 1999 Dec; 67(12):6510-7. PubMed ID: 10569769
[TBL] [Abstract][Full Text] [Related]
26. Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?
Roozendaal C; Kallenberg CG
Clin Exp Immunol; 1999 May; 116(2):206-13. PubMed ID: 10337008
[TBL] [Abstract][Full Text] [Related]
27. Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses.
Yang H; Plevy SE; Taylor K; Tyan D; Fischel-Ghodsian N; McElree C; Targan SR; Rotter JI
Gut; 1999 Apr; 44(4):519-26. PubMed ID: 10075959
[TBL] [Abstract][Full Text] [Related]
28. Biased JH usage in plasma cell immunoglobulin gene sequences from colonic mucosa in ulcerative colitis but not in Crohn's disease.
Dunn-Walters DK; Boursier L; Hackett M; Spencer J
Gut; 1999 Mar; 44(3):382-6. PubMed ID: 10026325
[TBL] [Abstract][Full Text] [Related]
29. Genetic markers in clinically well defined patients with ulcerative colitis (UC).
Bouma G; Crusius JB; García-González MA; Meijer BU; Hellemans HP; Hakvoort RJ; Schreuder GM; Kostense PJ; Meuwissen SG; Peña AS
Clin Exp Immunol; 1999 Feb; 115(2):294-300. PubMed ID: 9933456
[TBL] [Abstract][Full Text] [Related]
30. Polymorphism of motilin gene in patients with Crohn's disease.
Annese V; Piepoli A; Andriulli A; Napolitano G; Bisceglia L; Zelante L; Gasparini P
Dig Dis Sci; 1998 Apr; 43(4):715-9. PubMed ID: 9558024
[TBL] [Abstract][Full Text] [Related]
31. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis.
Hacker UT; Gomolka M; Keller E; Eigler A; Folwaczny C; Fricke H; Albert E; Loeschke K; Endres S
Gut; 1997 May; 40(5):623-7. PubMed ID: 9203941
[TBL] [Abstract][Full Text] [Related]
32. Myopericarditis, pleuritis and deep venous thrombosis in ulcerative colitis masquerading as pulmonary embolism.
Stajer D; Gorjup V
Intensive Care Med; 1996 Oct; 22(10):1134-5. PubMed ID: 8923087
[No Abstract] [Full Text] [Related]
33. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD).
Bouma G; Xia B; Crusius JB; Bioque G; Koutroubakis I; Von Blomberg BM; Meuwissen SG; Peña AS
Clin Exp Immunol; 1996 Mar; 103(3):391-6. PubMed ID: 8608636
[TBL] [Abstract][Full Text] [Related]
34. Current concepts of the pathogenesis of inflammatory bowel disease.
Shanahan F
Ir J Med Sci; 1994 Dec; 163(12):544-9. PubMed ID: 7843934
[TBL] [Abstract][Full Text] [Related]
35. Serological markers to differentiate between ulcerative colitis and Crohn's disease.
Oudkerk Pool M; Bouma G; Meuwissen SG; von Blomberg BM; van de Merwe JP; Devillé WL; Fonk JC; Peña AS
J Clin Pathol; 1995 Apr; 48(4):346-50. PubMed ID: 7615855
[TBL] [Abstract][Full Text] [Related]
36. P-ANCA in monozygotic twins with inflammatory bowel disease.
Yang P; Järnerot G; Danielsson D; Tysk C; Lindberg E
Gut; 1995 Jun; 36(6):887-90. PubMed ID: 7615278
[TBL] [Abstract][Full Text] [Related]
37. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
Yang H; Rotter JI; Toyoda H; Landers C; Tyran D; McElree CK; Targan SR
J Clin Invest; 1993 Aug; 92(2):1080-4. PubMed ID: 8349790
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers.
Hirv K; Seyfarth M; Uibo R; Kull K; Salupere R; Latza U; Rink L
Scand J Gastroenterol; 1999 Oct; 34(10):1025-32. PubMed ID: 10563674
[TBL] [Abstract][Full Text] [Related]
39. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis?
Heresbach D; Alizadeh M; Reumaux D; Colombel JF; Delamaire M; Danze PM; Gosselin M; Genetet B; Bretagne JF; Semana G
J Autoimmun; 1996 Dec; 9(6):777-84. PubMed ID: 9115580
[TBL] [Abstract][Full Text] [Related]
40. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder.
Perri F; Annese V; Piepoli A; Napolitano G; Lombardi G; Ciavarella G; Di Giorgio G; Andriulli A
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):56-61. PubMed ID: 9615268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
